Heidi Irma Louisa Jacobs, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Locus Coeruleus | 20 | 2023 | 176 | 6.950 |
Why?
|
| Alzheimer Disease | 64 | 2023 | 8037 | 5.870 |
Why?
|
| Amyloid beta-Peptides | 38 | 2023 | 3587 | 2.510 |
Why?
|
| tau Proteins | 28 | 2023 | 1868 | 2.330 |
Why?
|
| Memory | 11 | 2022 | 2174 | 1.890 |
Why?
|
| Norepinephrine | 5 | 2022 | 909 | 1.720 |
Why?
|
| Parietal Lobe | 8 | 2018 | 838 | 1.480 |
Why?
|
| Parahippocampal Gyrus | 4 | 2020 | 116 | 1.360 |
Why?
|
| Brain | 38 | 2023 | 26385 | 1.160 |
Why?
|
| Hippocampus | 11 | 2021 | 3675 | 1.110 |
Why?
|
| Positron-Emission Tomography | 31 | 2023 | 6234 | 1.040 |
Why?
|
| Magnetic Resonance Imaging | 56 | 2023 | 35421 | 1.030 |
Why?
|
| Brain Mapping | 19 | 2022 | 6669 | 0.930 |
Why?
|
| Arteriolosclerosis | 1 | 2023 | 21 | 0.900 |
Why?
|
| Hypopigmentation | 1 | 2023 | 41 | 0.890 |
Why?
|
| Solitary Nucleus | 2 | 2021 | 63 | 0.880 |
Why?
|
| Cognition Disorders | 8 | 2018 | 4043 | 0.850 |
Why?
|
| Cerebellum | 3 | 2023 | 1488 | 0.830 |
Why?
|
| Cerebral Cortex | 9 | 2021 | 5708 | 0.800 |
Why?
|
| Memory Disorders | 5 | 2023 | 1184 | 0.800 |
Why?
|
| Longevity | 2 | 2020 | 1070 | 0.790 |
Why?
|
| Salivary alpha-Amylases | 1 | 2021 | 16 | 0.780 |
Why?
|
| CADASIL | 1 | 2021 | 84 | 0.740 |
Why?
|
| Apolipoproteins E | 4 | 2022 | 1438 | 0.740 |
Why?
|
| Blood-Brain Barrier | 5 | 2019 | 1017 | 0.720 |
Why?
|
| Saliva | 2 | 2021 | 809 | 0.700 |
Why?
|
| Temporal Lobe | 8 | 2021 | 1670 | 0.680 |
Why?
|
| Leukoencephalopathies | 1 | 2021 | 238 | 0.640 |
Why?
|
| Nerve Net | 4 | 2021 | 2174 | 0.640 |
Why?
|
| Sympathetic Nervous System | 1 | 2021 | 514 | 0.620 |
Why?
|
| Cerebral Amyloid Angiopathy | 2 | 2023 | 859 | 0.620 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2022 | 604 | 0.610 |
Why?
|
| Cognition | 15 | 2023 | 6770 | 0.610 |
Why?
|
| Leukoaraiosis | 1 | 2018 | 120 | 0.600 |
Why?
|
| Aging | 11 | 2023 | 8664 | 0.580 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2014 | 957 | 0.570 |
Why?
|
| Aged | 66 | 2023 | 163280 | 0.560 |
Why?
|
| Neuropsychological Tests | 15 | 2021 | 6993 | 0.550 |
Why?
|
| Mental Processes | 3 | 2019 | 249 | 0.550 |
Why?
|
| Neural Pathways | 7 | 2018 | 2972 | 0.540 |
Why?
|
| Autopsy | 4 | 2023 | 1020 | 0.540 |
Why?
|
| Executive Function | 4 | 2021 | 1364 | 0.540 |
Why?
|
| Vascular Diseases | 1 | 2023 | 1161 | 0.480 |
Why?
|
| Learning | 3 | 2021 | 1713 | 0.480 |
Why?
|
| Dementia | 4 | 2019 | 2518 | 0.450 |
Why?
|
| Humans | 108 | 2023 | 744343 | 0.450 |
Why?
|
| Disease Progression | 16 | 2023 | 13284 | 0.440 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2015 | 161 | 0.440 |
Why?
|
| Tauopathies | 3 | 2021 | 307 | 0.430 |
Why?
|
| Middle Aged | 49 | 2023 | 213383 | 0.420 |
Why?
|
| Vagus Nerve | 1 | 2015 | 438 | 0.420 |
Why?
|
| Male | 72 | 2023 | 350118 | 0.410 |
Why?
|
| Visual Perception | 3 | 2019 | 1420 | 0.410 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2015 | 199 | 0.410 |
Why?
|
| Methoxyhydroxyphenylglycol | 2 | 2021 | 93 | 0.390 |
Why?
|
| Peptide Fragments | 6 | 2022 | 5097 | 0.390 |
Why?
|
| Aged, 80 and over | 33 | 2023 | 57776 | 0.390 |
Why?
|
| Organ Size | 6 | 2021 | 2252 | 0.380 |
Why?
|
| Female | 67 | 2023 | 380194 | 0.360 |
Why?
|
| Image Processing, Computer-Assisted | 10 | 2017 | 8949 | 0.360 |
Why?
|
| Amnesia | 1 | 2012 | 248 | 0.350 |
Why?
|
| Rest | 1 | 2014 | 901 | 0.350 |
Why?
|
| Reaction Time | 5 | 2019 | 2097 | 0.330 |
Why?
|
| Space Perception | 1 | 2012 | 475 | 0.320 |
Why?
|
| Pattern Recognition, Automated | 1 | 2015 | 1005 | 0.320 |
Why?
|
| Attention | 5 | 2019 | 2400 | 0.310 |
Why?
|
| Diffusion Tensor Imaging | 5 | 2021 | 2305 | 0.310 |
Why?
|
| Longitudinal Studies | 15 | 2022 | 13989 | 0.300 |
Why?
|
| Models, Neurological | 5 | 2021 | 1774 | 0.290 |
Why?
|
| Presenilin-1 | 2 | 2022 | 635 | 0.290 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2018 | 2737 | 0.280 |
Why?
|
| Stress, Psychological | 1 | 2021 | 4245 | 0.260 |
Why?
|
| Atrophy | 7 | 2023 | 1583 | 0.260 |
Why?
|
| Carbolines | 4 | 2020 | 265 | 0.250 |
Why?
|
| Frontal Lobe | 3 | 2018 | 1406 | 0.250 |
Why?
|
| Functional Laterality | 4 | 2018 | 2290 | 0.240 |
Why?
|
| Apolipoprotein E4 | 5 | 2020 | 668 | 0.240 |
Why?
|
| Software | 2 | 2015 | 4443 | 0.220 |
Why?
|
| Substantia Nigra | 2 | 2023 | 353 | 0.210 |
Why?
|
| Parkinson Disease | 3 | 2023 | 2775 | 0.210 |
Why?
|
| Melanins | 2 | 2023 | 289 | 0.210 |
Why?
|
| Radiopharmaceuticals | 4 | 2020 | 2645 | 0.210 |
Why?
|
| Cerebrovascular Circulation | 1 | 2011 | 2731 | 0.200 |
Why?
|
| Young Adult | 14 | 2023 | 56430 | 0.190 |
Why?
|
| Gyrus Cinguli | 2 | 2018 | 1091 | 0.190 |
Why?
|
| alpha-Amylases | 1 | 2020 | 41 | 0.190 |
Why?
|
| Entorhinal Cortex | 2 | 2019 | 272 | 0.190 |
Why?
|
| Sleep, REM | 1 | 2023 | 595 | 0.180 |
Why?
|
| Adult | 22 | 2023 | 214055 | 0.180 |
Why?
|
| Dementia, Vascular | 1 | 2021 | 128 | 0.180 |
Why?
|
| Extracellular Fluid | 1 | 2021 | 167 | 0.180 |
Why?
|
| Widowhood | 1 | 2020 | 54 | 0.180 |
Why?
|
| Psychomotor Performance | 2 | 2018 | 1901 | 0.180 |
Why?
|
| Linear Models | 4 | 2021 | 5952 | 0.180 |
Why?
|
| Nerve Degeneration | 2 | 2021 | 748 | 0.170 |
Why?
|
| Amyloidogenic Proteins | 1 | 2020 | 152 | 0.170 |
Why?
|
| Acetylcholinesterase | 1 | 2019 | 153 | 0.170 |
Why?
|
| Asymptomatic Diseases | 2 | 2019 | 551 | 0.170 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2019 | 105 | 0.170 |
Why?
|
| Activity Cycles | 1 | 2018 | 51 | 0.160 |
Why?
|
| Acetates | 1 | 2019 | 311 | 0.160 |
Why?
|
| Judgment | 1 | 2020 | 281 | 0.150 |
Why?
|
| Sex Characteristics | 4 | 2022 | 2585 | 0.150 |
Why?
|
| Early Diagnosis | 2 | 2012 | 1184 | 0.150 |
Why?
|
| Social Participation | 1 | 2019 | 173 | 0.150 |
Why?
|
| Cues | 2 | 2019 | 873 | 0.140 |
Why?
|
| Loneliness | 1 | 2018 | 185 | 0.140 |
Why?
|
| Plaque, Amyloid | 1 | 2020 | 729 | 0.140 |
Why?
|
| Brain Stem | 1 | 2022 | 846 | 0.140 |
Why?
|
| Sleep | 3 | 2023 | 4623 | 0.140 |
Why?
|
| Contrast Media | 5 | 2020 | 5300 | 0.140 |
Why?
|
| Affect | 1 | 2023 | 1476 | 0.130 |
Why?
|
| Choroid Plexus | 1 | 2018 | 231 | 0.130 |
Why?
|
| Pilot Projects | 2 | 2021 | 8324 | 0.130 |
Why?
|
| Gadolinium | 1 | 2019 | 952 | 0.120 |
Why?
|
| Aniline Compounds | 4 | 2019 | 986 | 0.120 |
Why?
|
| Auditory Perception | 1 | 2018 | 569 | 0.120 |
Why?
|
| Arousal | 1 | 2019 | 1165 | 0.120 |
Why?
|
| Cyclophosphamide | 1 | 2019 | 2242 | 0.120 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2013 | 98 | 0.110 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2019 | 2016 | 0.110 |
Why?
|
| Heterozygote | 1 | 2019 | 2804 | 0.100 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 15540 | 0.100 |
Why?
|
| Corpus Striatum | 1 | 2018 | 1221 | 0.100 |
Why?
|
| Image Enhancement | 2 | 2020 | 2921 | 0.100 |
Why?
|
| Amyloidosis | 1 | 2018 | 795 | 0.100 |
Why?
|
| Hypertension | 1 | 2011 | 8480 | 0.100 |
Why?
|
| Single-Blind Method | 1 | 2015 | 1590 | 0.100 |
Why?
|
| Piperidines | 1 | 2019 | 1602 | 0.100 |
Why?
|
| PubMed | 1 | 2011 | 123 | 0.100 |
Why?
|
| Inflammation | 2 | 2022 | 10638 | 0.100 |
Why?
|
| Cerebrovascular Disorders | 1 | 2017 | 1504 | 0.090 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 940 | 0.090 |
Why?
|
| Imagination | 1 | 2012 | 221 | 0.090 |
Why?
|
| Placebos | 1 | 2015 | 1676 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 1061 | 0.090 |
Why?
|
| Risk | 2 | 2019 | 9687 | 0.090 |
Why?
|
| Mental Status Schedule | 1 | 2011 | 321 | 0.090 |
Why?
|
| Brain Injuries | 1 | 2022 | 2025 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2019 | 3200 | 0.090 |
Why?
|
| Computers | 1 | 2012 | 612 | 0.090 |
Why?
|
| Cross-Over Studies | 1 | 2015 | 2029 | 0.090 |
Why?
|
| Colombia | 2 | 2021 | 258 | 0.090 |
Why?
|
| Heart Rate | 1 | 2020 | 4091 | 0.080 |
Why?
|
| Anisotropy | 1 | 2012 | 1265 | 0.080 |
Why?
|
| Ethylene Glycols | 2 | 2019 | 156 | 0.080 |
Why?
|
| Thiazoles | 3 | 2019 | 1483 | 0.070 |
Why?
|
| Animals | 5 | 2023 | 168757 | 0.070 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 2031 | 0.070 |
Why?
|
| Biological Evolution | 1 | 2013 | 1076 | 0.070 |
Why?
|
| Circadian Rhythm | 1 | 2018 | 2624 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 15076 | 0.070 |
Why?
|
| Brain Ischemia | 1 | 2020 | 3265 | 0.070 |
Why?
|
| Gadolinium DTPA | 2 | 2020 | 836 | 0.070 |
Why?
|
| Depressive Disorder, Major | 1 | 2023 | 4644 | 0.070 |
Why?
|
| Causality | 1 | 2012 | 1275 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2018 | 3327 | 0.060 |
Why?
|
| Time Factors | 3 | 2018 | 40075 | 0.060 |
Why?
|
| Age Factors | 1 | 2020 | 18370 | 0.060 |
Why?
|
| ROC Curve | 1 | 2011 | 3527 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2021 | 40561 | 0.050 |
Why?
|
| Prognosis | 2 | 2021 | 29063 | 0.050 |
Why?
|
| Cross-Sectional Studies | 5 | 2023 | 25043 | 0.050 |
Why?
|
| Phantoms, Imaging | 2 | 2020 | 2480 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 2716 | 0.050 |
Why?
|
| Capsaicin | 1 | 2021 | 231 | 0.050 |
Why?
|
| Adolescent | 6 | 2019 | 85781 | 0.040 |
Why?
|
| Spectrum Analysis | 1 | 2021 | 454 | 0.040 |
Why?
|
| Occipital Lobe | 1 | 2020 | 379 | 0.040 |
Why?
|
| Reflex | 1 | 2020 | 365 | 0.040 |
Why?
|
| Exudates and Transudates | 1 | 2019 | 172 | 0.040 |
Why?
|
| Physical Stimulation | 1 | 2019 | 525 | 0.040 |
Why?
|
| Neurofibrillary Tangles | 1 | 2020 | 439 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 7785 | 0.040 |
Why?
|
| Stroke | 1 | 2020 | 9981 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2013 | 7729 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2013 | 13033 | 0.040 |
Why?
|
| Mutation | 1 | 2022 | 29786 | 0.040 |
Why?
|
| Wakefulness | 1 | 2023 | 1245 | 0.040 |
Why?
|
| Fibrin | 1 | 2019 | 506 | 0.030 |
Why?
|
| Cold Temperature | 1 | 2019 | 772 | 0.030 |
Why?
|
| Prospective Studies | 4 | 2023 | 53288 | 0.030 |
Why?
|
| Semantics | 1 | 2019 | 584 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2011 | 8554 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2019 | 798 | 0.030 |
Why?
|
| Models, Biological | 1 | 2011 | 9583 | 0.030 |
Why?
|
| Sex Factors | 2 | 2019 | 10397 | 0.030 |
Why?
|
| Microvessels | 1 | 2019 | 544 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2023 | 2969 | 0.030 |
Why?
|
| Melanocytes | 1 | 2018 | 515 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 2018 | 1216 | 0.030 |
Why?
|
| Menopause | 1 | 2022 | 1626 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 2959 | 0.030 |
Why?
|
| Risk Factors | 3 | 2020 | 72290 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2019 | 1124 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 1107 | 0.030 |
Why?
|
| Diazepam Binding Inhibitor | 1 | 2013 | 4 | 0.030 |
Why?
|
| Amyloid | 1 | 2017 | 795 | 0.030 |
Why?
|
| Mice | 1 | 2019 | 81183 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2018 | 2025 | 0.030 |
Why?
|
| Forecasting | 1 | 2020 | 2951 | 0.020 |
Why?
|
| Perception | 1 | 2017 | 1198 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 1889 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2020 | 77449 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2017 | 6365 | 0.020 |
Why?
|
| Boston | 1 | 2021 | 9313 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 39050 | 0.020 |
Why?
|
| Self Report | 1 | 2018 | 3558 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2013 | 1117 | 0.020 |
Why?
|
| Brain Concussion | 1 | 2018 | 1320 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 4560 | 0.020 |
Why?
|
| Life Style | 1 | 2018 | 3835 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2017 | 8436 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2017 | 6038 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 12245 | 0.020 |
Why?
|
| Cerebral Hemorrhage | 1 | 2017 | 2647 | 0.020 |
Why?
|
| Oxygen | 1 | 2017 | 4189 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2013 | 2012 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2019 | 6150 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2020 | 21746 | 0.010 |
Why?
|
| Quality of Life | 1 | 2023 | 12804 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 14722 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20129 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 17446 | 0.010 |
Why?
|
| Child | 1 | 2019 | 77709 | 0.010 |
Why?
|